logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 9
  • 1
    Jarmin, Sarah Jane, Dr
    Commercialisation Manager born in December 1974
    Individual (4 offsprings)
    Officer
    2019-09-20 ~ 2023-12-12
    OF - Director → CIF 0
  • 2
    Duley, Andrew John Michael
    Director born in May 1969
    Individual (18 offsprings)
    Officer
    2018-04-18 ~ 2019-11-15
    OF - Director → CIF 0
  • 3
    Howell, Julian David
    Ceo born in September 1966
    Individual (7 offsprings)
    Officer
    2022-02-23 ~ 2025-06-30
    OF - Director → CIF 0
  • 4
    Philippou, Helen, Professor
    Born in March 1968
    Individual (2 offsprings)
    Officer
    2018-04-18 ~ now
    OF - Director → CIF 0
  • 5
    Canning, Mary Eugenie, Dr
    Born in June 1974
    Individual (5 offsprings)
    Officer
    2019-09-20 ~ now
    OF - Director → CIF 0
  • 6
    Turner, Mervyn
    Born in August 1946
    Individual (2 offsprings)
    Officer
    2019-10-04 ~ now
    OF - Director → CIF 0
  • 7
    Finan, Peter Michael, Dr
    Born in July 1967
    Individual (22 offsprings)
    Officer
    2019-09-20 ~ now
    OF - Director → CIF 0
  • 8
    EPIDAREX CAPITAL III UK,LP
    EPIDAREX CAPITAL III UK, LP SL033678 SL033675... (more)
    137a, George Street, Edinburgh, Scotland
    Active Corporate (4 parents, 8 offsprings)
    Person with significant control
    2019-09-20 ~ now
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
  • 9
    Nerine Chambers, Po Box 905, Po Box 905, Tortola, Tortola, British Virgin Islands, United Kingdom
    Corporate (1 offspring)
    Person with significant control
    2020-05-06 ~ 2020-05-06
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

LUNAC THERAPEUTICS LIMITED

Period: 2018-04-18 ~ now
Company number: 11317849
Registered name
LUNAC THERAPEUTICS LIMITED - now
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Property, Plant & Equipment
0 GBP2024-05-31
617 GBP2023-05-31
Debtors
68,811 GBP2024-05-31
741,830 GBP2023-05-31
Cash at bank and in hand
774,992 GBP2024-05-31
455,169 GBP2023-05-31
Current Assets
843,803 GBP2024-05-31
1,196,999 GBP2023-05-31
Creditors
Current, Amounts falling due within one year
-67,643 GBP2024-05-31
-4,808,178 GBP2023-05-31
Net Current Assets/Liabilities
776,160 GBP2024-05-31
-3,611,179 GBP2023-05-31
Total Assets Less Current Liabilities
776,160 GBP2024-05-31
-3,610,562 GBP2023-05-31
Creditors
Non-current, Amounts falling due after one year
0 GBP2023-05-31
Net Assets/Liabilities
-3,928,384 GBP2024-05-31
-3,610,562 GBP2023-05-31
Equity
Called up share capital
4 GBP2024-05-31
4 GBP2023-05-31
Share premium
5,469,369 GBP2024-05-31
5,469,369 GBP2023-05-31
Retained earnings (accumulated losses)
-9,397,757 GBP2024-05-31
-9,079,935 GBP2023-05-31
Equity
-3,928,384 GBP2024-05-31
-3,610,562 GBP2023-05-31
Average Number of Employees
12023-06-01 ~ 2024-05-31
12022-06-01 ~ 2023-05-31
Property, Plant & Equipment - Gross Cost
Other
99,638 GBP2023-05-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
99,638 GBP2024-05-31
99,021 GBP2023-05-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
617 GBP2023-06-01 ~ 2024-05-31
Property, Plant & Equipment
Other
0 GBP2024-05-31
617 GBP2023-05-31
Amount of corporation tax that is recoverable
Current
58,556 GBP2024-05-31
702,658 GBP2023-05-31
Other Debtors
Amounts falling due within one year
10,255 GBP2024-05-31
39,172 GBP2023-05-31
Debtors
Current, Amounts falling due within one year
68,811 GBP2024-05-31
741,830 GBP2023-05-31
Trade Creditors/Trade Payables
Current
45,700 GBP2024-05-31
360,476 GBP2023-05-31
Other Taxation & Social Security Payable
Current
1,938 GBP2024-05-31
7,895 GBP2023-05-31
Other Creditors
Current
20,005 GBP2024-05-31
148,869 GBP2023-05-31
Creditors
Current
67,643 GBP2024-05-31
4,808,178 GBP2023-05-31
Equity
Called up share capital
4 GBP2024-05-31
4 GBP2023-05-31

  • LUNAC THERAPEUTICS LIMITED
    Info
    Registered number 11317849
    Nexus, Discovery Way, Leeds, Yorks LS2 3AA
    PRIVATE LIMITED COMPANY incorporated on 2018-04-18 (7 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-04-17
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 March 2026 and licensed under the Open Government Licence v3.0.